SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+5.62%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$652M
AUM Growth
+$652M
(+64%)
Cap. Flow
+$238M
Cap. Flow
% of AUM
36.52%
Top 10 Holdings %
Top 10 Hldgs %
43.69%
Holding
147
New
54
Increased
27
Reduced
34
Closed
24
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$29.5M |
| 2 |
AbbVie
ABBV
|
$23.3M |
| 3 |
ISRL
Isramco Inc
ISRL
|
$22.1M |
| 4 |
Pfizer
PFE
|
$18.3M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$16.8M |
Top Sells
| 1 |
Sanofi
SNY
|
$12.7M |
| 2 |
GSK
GSK
|
$9.33M |
| 3 |
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
|
$8.94M |
| 4 |
Biogen
BIIB
|
$6.94M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$5.3M |
Sector Composition
| 1 | Healthcare | 70.86% |
| 2 | Technology | 5.53% |
| 3 | Energy | 3.84% |
| 4 | Industrials | 3.33% |
| 5 | Materials | 1.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDVN
26
DELISTED
MEDIVATION, INC.
MDVN
| $6.24M | 0.77% |
63,115
-6,885
| -10% | -$681K |
|
|
BCOM
27
DELISTED
B Communications Ltd
BCOM
| $6.18M | 0.76% |
321,431
+79,726
| +33% | +$1.53M |
|
|
MDAS
28
DELISTED
MEDASSETS INC COM STK (DE)
MDAS
| $6.1M | 0.75% |
+433,889
| New | +$6.1M |
|
|
SGEN
29
DELISTED
Seagen Inc. Common Stock
SGEN
| $5.78M | 0.71% |
155,360
-142,440
| -48% | -$5.3M |
|
|
DYAX
30
DELISTED
DYAX CORPORATION
DYAX
| $5.24M | 0.65% |
517,556
-132,444
| -20% | -$1.34M |
|
31
Apple
AAPL
$3.54T
| $5.04M | 0.62% |
+50,045
| New | +$5.04M |
|
32
Ituran Location and Control
ITRN
$653M
| $4.86M | 0.6% |
+231,115
| New | +$4.86M |
|
33
Alphabet (Google) Class C
GOOG
$2.79T
| $4.85M | 0.6% |
8,324
| – | – |
|
|
AMAG
34
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $4.79M | 0.59% |
+150,230
| New | +$4.79M |
|
|
CLVS
35
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.63M | 0.57% |
101,955
-3,045
| -3% | -$138K |
|
|
PCYC
36
DELISTED
PHARMACYCLICS INC
PCYC
| $4.56M | 0.56% |
38,840
-11,160
| -22% | -$1.31M |
|
37
CSX Corp
CSX
$60.2B
| $4.48M | 0.55% |
139,675
-8,650
| -6% | -$277K |
|
|
38
GSK
GSK
$79.3B
| $4.46M | 0.55% |
97,100
-202,900
| -68% | -$9.33M |
|
39
Viatris
VTRS
$12.3B
| $4.42M | 0.55% |
+97,100
| New | +$4.42M |
|
|
ASPX
40
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
| $4.24M | 0.52% |
+165,074
| New | +$4.24M |
|
|
BRCM
41
DELISTED
BROADCOM CORP CL-A
BRCM
| $4.02M | 0.5% |
99,360
+20,240
| +26% | +$818K |
|
|
AGTC
42
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $3.92M | 0.48% |
+210,724
| New | +$3.92M |
|
|
NPSP
43
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $3.63M | 0.45% |
139,420
+90,420
| +185% | +$2.35M |
|
44
Union Pacific
UNP
$132B
| $3.5M | 0.43% |
+32,312
| New | +$3.5M |
|
45
Eledon Pharmaceuticals
ELDN
$155M
| $3.48M | 0.43% |
+230,000
| New | +$3.48M |
|
|
ICPT
46
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.45M | 0.43% |
+14,565
| New | +$3.45M |
|
47
ProQR Therapeutics
PRQR
$256M
| $3.44M | 0.42% |
+200,000
| New | +$3.44M |
|
|
AERI
48
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $3.38M | 0.42% |
163,516
+53,516
| +49% | +$1.11M |
|
|
CBAY
49
DELISTED
Cymabay Therapeutics
CBAY
| $3.35M | 0.41% |
+490,355
| New | +$3.35M |
|
50
CVS Health
CVS
$93B
| $3.17M | 0.39% |
39,810
+20,515
| +106% | +$1.63M |
|